Riboflavin
- Generic Name
- Riboflavin
- Brand Names
- Alertonic, Concept Ob, Irospan 24/6 Kit, Mvc-fluoride, Natafort, Pregvit, Tandem Plus, Vitafol-one
- Drug Type
- Small Molecule
- Chemical Formula
- C17H20N4O6
- CAS Number
- 83-88-5
- Unique Ingredient Identifier
- TLM2976OFR
- Background
Nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables. The richest natural source is yeast. It occurs in the free form only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as flavin mononucleotide and flavin-adenine dinucleotide.
- Indication
For the treatment of ariboflavinosis (vitamin B2 deficiency).
- Associated Conditions
- Ariboflavinosis, Beriberi, Constipation, Functional Gastrointestinal Disorders (FGID), Joint Pain, Metabolic cardiomyopathy, Migraine, Myalgia, Neuropathic Pain, Peripheral neuritis, Peripheral paralysis, Vitamin B complex deficiency, Vitamin B1 deficiency, Vitamin Deficiency, Wernicke's encephalopathy
- Associated Therapies
- Dietary and Nutritional Therapies, Nutritional supplementation, Vitamin supplementation, Dietary supplementation
Corneal Crosslinking in Keratoconus and Corneal Ectasia
- Conditions
- Progressive KeratoconusCorneal Ectasia
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-05-19
- Last Posted Date
- 2017-04-20
- Lead Sponsor
- Ohio State University
- Registration Number
- NCT00679666
- Locations
- 🇺🇸
OSU Havener Eye Institute, Dublin, Ohio, United States
🇺🇸The Ohio State University Medical Center, Columbus, Ohio, United States
Corneal Collagen Cross-Linking for Ectasia (CXL)
- Conditions
- Ectasia
- Interventions
- Device: UVA Irradiation
- First Posted Date
- 2008-05-08
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 130
- Registration Number
- NCT00674661
- Locations
- 🇺🇸
Gordon -Weiss Vision Institute, San Diego, California, United States
🇺🇸Edward Harkness Eye Institute at Columbia University Medical Center, New York, New York, United States
🇺🇸Shiley Eye Center, La Jolla, California, United States
Corneal Collagen Cross-linking for Progressive Keratoconus
- Conditions
- Progressive Keratoconus
- Interventions
- Device: UVA Irradiation
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 147
- Registration Number
- NCT00647699
- Locations
- 🇺🇸
Cornea & Laser Eye Institute; Hersh Vision Group, Teaneck, New Jersey, United States
🇺🇸Durrie Vision, Kansas City, Kansas, United States
🇺🇸Shiley Eye Center, La Jolla, California, United States
D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)
- Conditions
- Acidosis, Lactic
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2008-09-25
- Lead Sponsor
- University of British Columbia
- Target Recruit Count
- 80
- Registration Number
- NCT00143702
- Locations
- 🇨🇦
Positive Care Clinic, Toronto, Ontario, Canada
🇨🇦St. Paul's Hospital, Vancouver, British Columbia, Canada
A Study to See if Certain Antioxidants and Vitamins Will Keep Lactate Levels Down in Patients Taking Anti-HIV Drugs
- Conditions
- HIV Infections
- Locations
- 🇺🇸
Univ of Colorado Health Sciences Ctr, Denver, Colorado, United States
🇺🇸Case Western Reserve Univ, Cleveland, Ohio, United States
🇺🇸Univ of Pennsylvania, Philadelphia, Philadelphia, Pennsylvania, United States
Vitamin B Therapy for Hyperlactatemia
- Conditions
- HIV Infections
- First Posted Date
- 2002-02-22
- Last Posted Date
- 2011-02-28
- Target Recruit Count
- 225
- Registration Number
- NCT00031057
- Locations
- 🇺🇸
Case Western Reserve Univ, Cleveland, Ohio, United States
🇺🇸Univ of North Carolina, Chapel Hill, North Carolina, United States
🇺🇸Beth Israel Med Ctr, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.